Gender differences in cardiac hypertrophic remodeling

Area of Science:

• Cardiovascular Biology
• Pathophysiology
• Endocrinology

Background:

• Cardiac remodeling is a cellular and molecular response to cardiac injury, involving multiple cell types and leading to adverse outcomes.
• Sex differences in cardiovascular disease prevalence and outcomes are well-documented, suggesting a role for gender in cardiac remodeling.
• Existing research indicates males generally exhibit more pronounced cardiac remodeling than females.

Purpose of the Study:

• To review and synthesize current literature on the influence of gender on pathological cardiac remodeling.
• To elucidate how sex differences impact clinical outcomes and therapeutic responses in cardiac remodeling.
• To explore the potential role of estrogens in mitigating adverse cardiac remodeling.

Main Methods:

• Comprehensive literature review of studies investigating gender-based differences in cardiac remodeling.
• Analysis of research focusing on pathological cardiac remodeling following ischemia and hypertension.
• Examination of studies exploring the effects of sex hormones, particularly estrogens, on myocardial remodeling.

Main Results:

• Males typically display greater cardiac remodeling responses compared to females following cardiac injury.
• Sex differences contribute to varied clinical outcomes and therapeutic efficacies in cardiac remodeling.
• Estrogens show potential in attenuating adverse cardiac remodeling, though specific mechanisms are not fully understood.

Conclusions:

• Gender is a critical determinant of pathological cardiac remodeling and subsequent clinical outcomes.
• Further research is needed to identify the precise mechanisms by which gender modulates myocardial remodeling.
• Understanding these sex differences is crucial for developing sex-specific therapeutic strategies for cardiovascular diseases.